Dehne T

No ORCID on file · 1 paper in corpus

2021

Therapies with CCL25 require controlled release via microparticles to avoid strong inflammatory reactions.

Journal of nanobiotechnology ·doi:10.1186/s12951-021-00830-7

BackgroundChemokine therapy with C-C motif chemokine ligand 25 (CCL25) is currently under investigation as a promising approach to treat articular cartilage degeneration. We developed a delayed release mechanism based on Poly (lactic-co-gly…